Monoclonal antibody therapies for COVID-19: lessons learned and implications for the development of future products

詳細情報 詳細情報について

• CRID

  1360580235926170240

• DOI

  10.1016/j.copbio.2022.102798

• ISSN

  09581669

• Web Site

  https://api.elsevier.com/content/article/PII:S095816692200132X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S095816692200132X?httpAccept=text/plain

• データソース種別

  • Crossref